Oncologist management of NTRK fusion-positive NSCLC improves after virtual patient simulation participation.

e23008Background: Although relatively rare, neurotrophic receptor tyrosine kinase (NTRK) fusions, represent a clinically relevant subgroup of NSCLC that can derive benefit from targeted therapies. ...